Forte Biosciences (FBRX) EPS (Diluted) (2021 - 2026)
Forte Biosciences (FBRX) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.33 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.15 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.19 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Forte Biosciences | 1.63 Bn | 1.28 Bn | - | -27.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.71 |
| Mar 31, 2026 | -26.29 |
| Dec 31, 2025 | -29.24 |
| Sep 30, 2025 | -42.52 |
| Jun 30, 2025 | -29.23 |
| Mar 31, 2025 | -18.60 |
| Dec 31, 2024 | -8.83 |
| Sep 30, 2024 | -10.28 |
| Jun 30, 2024 | -15.26 |
| Mar 31, 2024 | -9.30 |
| Dec 31, 2023 | -7.62 |
| Sep 30, 2023 | -12.14 |
| Jun 30, 2023 | -10.83 |
| Mar 31, 2023 | -8.24 |
| Dec 31, 2022 | -7.20 |
| Sep 30, 2022 | -4.65 |
| Jun 30, 2022 | -5.48 |
| Mar 31, 2022 | -4.77 |
| Dec 31, 2021 | -7.01 |
| Sep 30, 2021 | -15.33 |